Conexeu Sciences, Inc. (CNXU)

3.41 -0.24 (-6.45%) USD  |  NASDAQ  |  Oct 15, 10:54
More

Conexeu Sciences Total Long Term Debt (Quarterly) : 0.0332M for July 31, 2026

Total Long Term Debt (Quarterly) Chart

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2024. Start Trial.
Date Value
July 31, 2026 0.0332M
April 30, 2026 0.00
January 31, 2026 0.00
Date Value
October 31, 2025 0.00
April 30, 2025 0.00
October 31, 2024 0.0981M

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
AbbVie, Inc. 70.82B
Vericel Corp. 80.41M
ACADIA Pharmaceuticals, Inc. 59.55M
Alnylam Pharmaceuticals, Inc. 2.942B
Anika Therapeutics, Inc. 23.32M